- Home
- ETON vs FFWM Comparison
ETON vs FFWM Comparison
Compare ETON & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- FFWM
- Stock Information
- Founded
- ETON 2017
- FFWM 1990
- Country
- ETON United States
- FFWM United States
- Employees
- ETON N/A
- FFWM N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- FFWM Major Banks
- Sector
- ETON Health Care
- FFWM Finance
- Exchange
- ETON Nasdaq
- FFWM Nasdaq
- Market Cap
- ETON 428.5M
- FFWM 378.0M
- IPO Year
- ETON 2018
- FFWM 2014
- Fundamental
- Price
- ETON $17.21
- FFWM $5.32
- Analyst Decision
- ETON Strong Buy
- FFWM Buy
- Analyst Count
- ETON 3
- FFWM 4
- Target Price
- ETON $27.67
- FFWM $6.75
- AVG Volume (30 Days)
- ETON 221.4K
- FFWM 948.7K
- Earning Date
- ETON 05-13-2025
- FFWM 04-30-2025
- Dividend Yield
- ETON N/A
- FFWM N/A
- EPS Growth
- ETON N/A
- FFWM N/A
- EPS
- ETON N/A
- FFWM N/A
- Revenue
- ETON $39,011,000.00
- FFWM $113,564,000.00
- Revenue This Year
- ETON $92.33
- FFWM $195.68
- Revenue Next Year
- ETON $52.62
- FFWM $11.62
- P/E Ratio
- ETON N/A
- FFWM N/A
- Revenue Growth
- ETON 23.29
- FFWM N/A
- 52 Week Low
- ETON $3.18
- FFWM $4.42
- 52 Week High
- ETON $18.41
- FFWM $8.52
- Technical
- Relative Strength Index (RSI)
- ETON 70.21
- FFWM 57.34
- Support Level
- ETON $16.43
- FFWM $5.12
- Resistance Level
- ETON $17.49
- FFWM $5.44
- Average True Range (ATR)
- ETON 0.85
- FFWM 0.23
- MACD
- ETON 0.18
- FFWM 0.03
- Stochastic Oscillator
- ETON 98.09
- FFWM 70.95
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.